- Home
- PBYI vs MED Comparison
PBYI vs MED Comparison
Compare PBYI & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- MED
- Stock Information
- Founded
- PBYI 2010
- MED 1980
- Country
- PBYI United States
- MED United States
- Employees
- PBYI N/A
- MED N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- PBYI Health Care
- MED Consumer Staples
- Exchange
- PBYI Nasdaq
- MED Nasdaq
- Market Cap
- PBYI 171.7M
- MED 152.3M
- IPO Year
- PBYI N/A
- MED N/A
- Fundamental
- Price
- PBYI $4.56
- MED $13.82
- Analyst Decision
- PBYI Strong Buy
- MED Hold
- Analyst Count
- PBYI 1
- MED 1
- Target Price
- PBYI $7.00
- MED $16.50
- AVG Volume (30 Days)
- PBYI 980.5K
- MED 164.1K
- Earning Date
- PBYI 11-06-2025
- MED 11-03-2025
- Dividend Yield
- PBYI N/A
- MED N/A
- EPS Growth
- PBYI 434.29
- MED N/A
- EPS
- PBYI 0.97
- MED 0.33
- Revenue
- PBYI $238,062,000.00
- MED $480,449,000.00
- Revenue This Year
- PBYI N/A
- MED N/A
- Revenue Next Year
- PBYI N/A
- MED N/A
- P/E Ratio
- PBYI $4.75
- MED $41.07
- Revenue Growth
- PBYI 8.63
- MED N/A
- 52 Week Low
- PBYI $2.25
- MED $11.57
- 52 Week High
- PBYI $6.07
- MED $21.98
- Technical
- Relative Strength Index (RSI)
- PBYI 47.28
- MED 50.30
- Support Level
- PBYI $4.93
- MED $13.71
- Resistance Level
- PBYI $5.22
- MED $14.24
- Average True Range (ATR)
- PBYI 0.32
- MED 0.50
- MACD
- PBYI -0.10
- MED 0.00
- Stochastic Oscillator
- PBYI 7.37
- MED 42.86
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.